Archive
All news, publications, and updates from Seek Labs.
Seek Labs Joins Global African Swine Fever Research Alliance (GARA) September 16, 2024 Seek Labs is excited to announce its participation in the Global African Swine Fever Research Alliance (GARA), a global collaborative effort dedicated to fighting African Swine Fever (ASF). With its innovative CRISPR-based therapeutic technology platform, Seek Labs is set to play a…
Doug Gladue, VP of Veterinary Pharmaceutical Development, Presents at PROCINORTE Priority Animal Diseases 2024 Workshop June 12, 2024 Today, Dr. Douglas Gladue, VP of Veterinary Pharmaceutical Development, presented at the PROCINORTE 2024 Priority Animal Diseases Virtual Workshop. Dr. Gladue spoke about Seek Labs’ development of CRISPR-based pharmaceuticals for human and animal diseases. Addressing a virtual assembly…
Renowned African Swine Fever Researcher, Douglas Gladue, PhD, joins Seek Labs as Vice President of Veterinary Pharmaceutical Development June 3, 2024 SALT LAKE CITY, UTAH, June 3, 2024 (Business Wire)– Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based pharmaceutical technology, is pleased to announce the appointment of Dr.…
Dr. Alison O’Mahony, Vice President of Pharmaceutical Research, Named One of 30 Women to Watch 2024 by Utah Business May 30, 2024 This week, Alison O’Mahony, VP of Pharmaceutical Research, was named one of 30 Women to Watch by Utah Business. Each year, Utah Business honors 30 women throughout the state of Utah who are…
Seek Labs Announces Successful Completion of African Swine Fever Virus In Vivo Trial Utilizing CRISPR-based Treatments May 6, 2024 SALT LAKE CITY, UT (Business Wire) – Seek Labs, a healthcare innovations company developing next-generation point-of-care molecular diagnostic systems and novel CRISPR-based gene therapies, announced today the successful completion of a therapeutic trial using innovative CRISPR-based…
Seek Labs Welcomes Alison O’Mahony, PhD as new Vice President of Pharmaceutical Research February 22, 2024 SALT LAKE CITY, UT, February 22, 2024 (BusinessWire) – Seek Labs, a healthcare innovations company developing next-generation molecular diagnostic systems and novel gene therapies, announced today the appointment of Alison O’Mahony, PhD as Vice President of Pharmaceutical Development. With…
Seek Labs Presents at the Animal Health, Nutrition & Technology Innovation Asia Summit in Tokyo, Japan October 18, 2023 SALT LAKE CITY, UT, October, 18, 2023 – Seek Labs, a healthcare innovations company doing research in infectious disease diagnostic systems and pharmaceuticals, is pleased to announce its participation at the Animal Health, Nutrition & Technology…
Seek Labs Advisor, Ryan Jackson, PhD, and Research Scientist, Dylan Keiser, M.S., published in Prestigious Scientific Journal, Nature January 4, 2023 SALT LAKE CITY, UT, January 4, 2023 — Seek Labs, a healthcare innovations company doing research in infectious disease diagnostic systems and pharmaceuticals, is proud to announce an esteemed advisor, Ryan Jackson PhD, and…
Craig Mosman and Dr. Ryan Jackson visit IZS and IZSUM May 21, 2022 SALT LAKE CITY, UT, May 21, 2022 — Seek Labs, a healthcare innovations company doing research in infectious disease diagnostic systems and CRISPR-based pharmaceuticals, is pleased to share Craig Mosman, VP of Business Development, recently traveled to Italy with Dr. Ryan Jackson…
Stay connected
Stay connected to company milestones, scientific insights, and the work unfolding across BioSeeker, SAT, and Seek Diagnostics.